Interestingly, a study also found increased lipid peroxidation markers after SGLT2 inhibitor treatment in patients with diabetes, suggesting that ketogenesis induced by the inhibitor may also increase lipid peroxidation (169). Here, SLC5A2 is linked to diabetes mellitus.